KalVista Pharmaceuticals Appoints Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer
Position
Chief People Officer
Company
KalVista Pharmaceuticals
Description
KalVista Pharmaceuticals has announced the appointments of Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer, effective October 6, 2025. Both executives bring extensive experience to their respective roles and are expected to enhance the company's operational and human resources strategies.
Quick answer
KalVista Pharmaceuticals Appoints Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer (October 6, 2025). KalVista Pharmaceuticals is based in Cambridge, Massachusetts, United States.
- Who is the new Chief People Officer at KalVista Pharmaceuticals?
- KalVista Pharmaceuticals named Linea Aspesi Chief People Officer, announced October 6, 2025.
- What did KalVista Pharmaceuticals announce on October 6, 2025?
- KalVista Pharmaceuticals has announced the appointments of Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer, effective October 6, 2025. Both executives bring extensive experience to their respective roles and are expected to enhance the company's operational and human resources strategies.
- What does KalVista Pharmaceuticals do?
- KalVista Pharmaceuticals, Inc. is a pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors for diseases with significant unmet need.
- Where is KalVista Pharmaceuticals based?
- KalVista Pharmaceuticals is based in Cambridge, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Quotient Therapeutics (October 2, 2025), Climb Bio, Inc. (October 1, 2025), Symeres (October 1, 2025) and Tessellate Bio (October 1, 2025) also announced leadership changes within 45 days of KalVista Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in research and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Quotient Therapeutics Hires Andrew Bayliffe as Chief Development Officer (October 2, 2025)
- Climb Bio Appoints Susan Altschuller as Chief Financial Officer (October 1, 2025)
- Symeres Appoints Gabriella Gentile as Chief Operating Officer (October 1, 2025)
- Tessellate Bio Appoints Dr. Katie Chapman as Chief Scientific Officer (October 1, 2025)
- Inventiva Appoints Andrew Obenshain as Chief Executive Officer (October 1, 2025)
- Geron Corporation Appoints Ahmed ElNawawi as Chief Commercial Officer (October 13, 2025)
Who to call at KalVista Pharmaceuticals, and when
A new leader at KalVista Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day KalVista Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at KalVista Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at KalVista Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment KalVista Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
KalVista Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.